Cited by 37Neurotransmitter Receptor Influence on BehaviorMemory and Neural MechanismsNeuroscience and Neuropharmacology Research

Hippocampal and prefrontal dopamine D1/5 receptor involvement in the memory-enhancing effect of reboxetine

De Bundel, Dimitri, Femenía, Teresa, DuPont, Caitlin M., Konradsson-Geuken, Åsa, Feltmann, Kritin, Schilström, Björn, Lindskog, Maria·2013·International Journal of Neuropsychopharmacology

Abstract

Dopamine modulates cognitive functions through regulation of synaptic transmission and plasticity in the hippocampus and prefrontal cortex (PFC). Thus, dopamine dysfunction in depression may be particularly relevant for the cognitive symptoms. The norepinephrine transporter inhibitor reboxetine facilitates memory processing in both healthy volunteers and in depressed patients and increases dopamine release in both the hippocampus and PFC. We investigated the potential involvement of the hippocampal and PFC dopamine D1/5 receptors in the cognitive effects of reboxetine using the object recognition test in rats. Infusion of the D1/5 antagonist SCH23390 into the dorsal hippocampus or medial PFC prior to the exploration of the objects impaired memory. Conversely, infusion of the D1/5 agonist SKF81297 into the dorsal hippocampus or medial PFC facilitated memory. Reboxetine similarly facilitated recognition memory in healthy rats and the D1/5 antagonist SCH23390 reversed this effect when infused into the dorsal PFC, but not when infused into the hippocampus. Moreover, systemic reboxetine increased the levels of the NMDA subunit GluN2A in the PFC but not in the hippocampus. Finally, we demonstrate that a single dose of reboxetine does not affect immobility in the forced swim test but improves recognition memory in the Flinders sensitive line (FSL) rat model for depression. The present data in rats are in line with effects of reboxetine on memory formation in healthy volunteers and depressed patients and indicate the involvement of PFC dopamine D1/5 receptors.

Integrity signals

Registry

Crossref · 10.1017/s1461145713000370

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
De Bundel, D., Femenía, T., DuPont, C. M., Konradsson-Geuken, Å., Feltmann, K., Schilström, B., & Lindskog, M.
Affiliations
  • Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden
  • Karolinska Institutet (SE)
  • Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden
Corresponding author
Lindskog, Maria
Venue
International Journal of Neuropsychopharmacology
Published
2013-10-01
Volume
16
Issue
9
Pages
2041-2051
ISSN
  • 1461-1457 (ISSN-L)
  • 1469-5111
OpenAlex
W2060835688
Cited by
37
References
58
Citations by year
2025: 2 · 2024: 3 · 2023: 1 · 2022: 5 · 2021: 3 · 2020: 5 · 2019: 5 · 2018: 2 · 2017: 3 · 2015: 3 · 2014: 2 · 2013: 3
FWCI
1.31
Type
journal article
Language
en
Open access
closed
Locations
  • The International Journal of Neuropsychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
  • VUBIR (Vrije Universiteit Brussel) (submittedVersion)
Funders
  • Gunvor och Josef Anérs Siftelse
  • Svenska Läkaresällskapet
  • Socialstyrelsen
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
reboxetine, hippocampus, prefrontal cortex, recognition memory, norepinephrine transporter inhibitor, depression, Flinders Sensitive Line rats, GluN2A, NMDA receptor subunits, SCH 23390, SKF 81297, forced swim test, cognitive symptoms of depression
MeSH terms
Reboxetine, Animals, Antidepressive Agents, Behavior, Animal, Cognition, Depression, Disease Models, Animal, Hippocampus, Male, Morpholines, Motor Activity, Swimming, Time Factors, Receptors, N-Methyl-D-Aspartate, Rats, Sprague-Dawley, Prefrontal Cortex, Receptors, Dopamine D1, Dopamine Agonists, Dopamine Antagonists, Nootropic Agents, Adrenergic Uptake Inhibitors, Recognition, Psychology, Receptors, Dopamine D5, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review